WILMINGTON, N.C. -- AAIPharma Services Corp., a provider of pharmaceutical product development services, announced it has appointed Christopher Smith, CQE, RAC to vice president of quality and regulatory affairs.
The executive appointment is AAIPharma Services’ first since partnering last month with Water Street Healthcare Partners, a private equity firm focused exclusively on health care, to separate from AAIPharma Inc. and become an independent company.
Smith will lead the company’s efforts to counsel and support customers with their regulatory strategy and submission needs as well as head the company’s GMP compliance efforts. He brings to AAIPharma Services more than 30 years of experience in the pharmaceutical industry. Smith has held management positions in regulatory affairs and quality assurance with the U.S. Food and Drug Administration (FDA), Abbott Laboratories and Endeavor Pharmaceuticals. Most recently, he built the global quality assurance function for AAIPharma Services’ former parent company, AAIPharma Inc.
